Treatment for therapy-resistant myofascial pain using a handheld device
Official title: A Combination of Low-Energy Ultrasound, Electrical and Magnetic Field Stimulation in Patients With Therapy-Resistant Myofascial Pain Syndrome: A Randomized, Controlled, Double-Blind Multi-Center Study
Run by Sobet AG · NCT05851326 · Data updated 2026-11-12
This study tests whether a handheld device that uses sound and electrical stimulation can help people with chronic myofascial pain feel better when other treatments haven't worked.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 126 (estimated) |
| Sponsor | Sobet AG Industry-sponsored |
| Locations | 6 sites (Graz and 5 other locations) |
| Status | Recruiting |
| Started | May 25, 2023 |
| Main results expected | March 2027 |
| Study ends | June 2027 |
| Registry record updated | April 23, 2026 |
| Trial ID | NCT05851326 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 to 99 who have chronic pain from myofascial pain syndrome persisting for at least three months.
✕Probably not a fit
Patients with active implants, allergies to study medications, or those who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical investigation evaluates the effectiveness of the Sonodyn device, which combines low-energy ultrasound, electrical, and magnetic field stimulation, in treating chronic myofascial pain syndrome. The device is designed for non-invasive application over specific trigger points associated with pain in the lower back, neck, and tension headaches. Patients will receive either the active treatment or a sham treatment to assess the device's efficacy. The study aims to provide relief for individuals suffering from persistent pain that has not responded to conventional therapies.
Why it matters
Potential benefit: If successful, this treatment could significantly alleviate chronic pain for patients suffering from therapy-resistant myofascial pain syndrome.
How similar studies have gone: While the approach of using combined low-energy stimulation techniques is innovative, similar studies have shown promise in treating chronic pain conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female aged 18 to 99 years at screening * Patient has an understanding of the study and its procedures, agrees to its provisions, and gives written informed consent prior to any study-related procedures * Patient is suffering from one of the following chronic pain conditions originating from myofascial pain: * low back pain * tension headache * neck pain having been persisting for a minimum of 3 months and where myofascial pain syndrome is the pre-dominant cause for pain. * Patient is constant with respect to pain treatment for 1 week during the screening phase * A daily average NRS \>= 4 on 4 out of 7 days in the screening phase * Compliance with the daily status reporting requirements as demonstrated Exclusion Criteria: * Patients with active implants * Allergy against rescue medication used during the study * Pregnancy * Mental or physical impairments that represent a source of risk for handling the device * Patients with cerebral spams (epilepsy) * Patients with psychiatric diseases or somatoform pain disorders * Patients with oral morphine equivalent of more than 120mg daily dose * Patients taking centrally acting muscle relaxants like Sirdalud or benzodiacepines * Patients with a contraindication against NSAID's * Presence of artificial joints made from methylmethacrylate or polyethylene at stimulation site * Presence of ferromagnetic metal implants at stimulation site, especially aneurysm clips, dental implants, etc.
Where it's running
-
Schmerzambulanz, Krankenhaus der Elisabethinen Graz
Graz, Austria Recruiting -
Abteilung für Anästhesiologie und Intensivmedizin, Klinikum Klagenfurt am Wörthersee
Klagenfurt, Austria Recruiting -
Krankenhaus St. Vinzenz Zams
Zams, Austria Recruiting -
RSB Neurochirurgie AG, Salem-Spital Bern
Bern, Switzerland Recruiting -
Clinique de la Douleur, La Tour Hospital
Meyrin, Switzerland Recruiting -
Schmerzklinik Zürich AG
Zurich, Switzerland Recruiting
Study contacts
- Principal investigator: Rudolf Likar, Prof. Dr. — Klinikum Klagenfurt am Wörthersee
- Study coordinator: Lidia Anguiano, Dr.
- Email: lidia.anguiano@alirahealth.com
- Phone: +49 1511 0177825
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of Different Myofascial Release Techniques on Function in Chronic Neck Pain
This trial tests whether manual or self-applied myofascial release, in addition to standard therapy and exercise, can improve function and reduce pain in adults with chronic non-specific neck pain.
-
Using MR elastography to track how manual therapy changes painful lower-back tissues
This trial will see if a special MRI method (MR elastography) can show tissue changes in adults with chronic lower‑back myofascial pain after Tuina manual therapy compared with usual care.
-
Comparing physical therapy methods to improve head‑neck alignment in neck myofascial pain
This will test whether different physical therapy treatments—dry needling, trigger‑point therapy, Maitland mobilizations, TENS, and ultrasound—can improve head‑neck alignment and reduce symptoms in adults 20–40 with cervical myofascial pain.
-
Trigger point injections for low back pain relief
This study is testing whether trigger point injections can help people with lower back pain feel better and improve their ability to move after visiting the Emergency Department.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.